José L. Toro, Director, Lachman Consultants, wrote a recent article for Contract Pharma about improving the bioavailability and therapeutic efficiency of poorly soluble drugs. Here is a brief excerpt from the article: “Over forty percent (40%) of new chemical entities (NCEs) that are being developed confront the challenge of being poorly soluble in water. These […]